Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Sep;104(1):115743.
doi: 10.1016/j.diagmicrobio.2022.115743. Epub 2022 Jun 16.

A rare case of SARS-CoV-2 and influenza A virus super-infection

Maria-Cristina Arcangeletti  1 , Flora De Conto  1 , Sara Montecchini  1 , Mirko Buttrini  1 , Clara Maccari  1 , Carlo Chezzi  1 , Adriana Calderaro  2
Affiliations
Case Reports

A rare case of SARS-CoV-2 and influenza A virus super-infection

Maria-Cristina Arcangeletti et al. Diagn Microbiol Infect Dis. 2022 Sep.

Abstract

We report the first Italian case of SARS-CoV-2 and influenza A virus super-infection. Laboratory diagnosis revealed the presence of both agents' RNA specific sequences by molecular methods and infectious influenza A virus by cell culture methods.

Keywords: SARS-CoV-2; cell culture; influenza A; laboratory diagnosis; molecular methods; super-infection.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None.

Figures

Fig 1
Fig. 1
(Panels A): Immunofluorescence analysis of Influenza A (FLU A) antigen expression in MDCK SIAT-1 cell monolayers at 24h p.i. (right panel) by rapid cell culture method. (Panels B): virus-induced cytopathic effect in MDCK SIAT-1 cell monolayers at day 4 p.i. (right panel) by conventional cell culture method. CC = control (uninfected) cells. Bar = 50 μm.
See this image and copyright information in PMC

References

    1. Long B., Carius B.M., Chavez S., Liang S.Y., Brady W.J., Koyfman A., et al. Clinical update on COVID-19 for the emergency clinician: presentation and evaluation. Am J Emerg Med. 2022;54:46–57. doi: 10.1016/j.ajem.2022.01.028. - DOI - PMC - PubMed
    1. Escobedo R.A., Kaushal D., Singh D.K. Insights into the changing landscape of Coronavirus disease 2019. Front Cell Infect Microbiol. 2021;11 doi: 10.3389/fcimb.2021.761521. - DOI - PMC - PubMed
    1. Calderaro A., De Conto F., Buttrini M., Piccolo G., Montecchini S., Maccari C., et al. Human respiratory viruses, including SARS-CoV-2, circulating in the winter season 2019–2020 in Parma, Northern Italy. Int J Infect Dis. 2021;102:79–84. doi: 10.1016/j.ijid.2020.09.1473. - DOI - PMC - PubMed
    1. Wu X., Cai Y., Huang X., Yu X., Zhao L., Wang F., et al. Co-infection with SARS-CoV-2 and influenza a virus in patient with pneumonia, China. Emerg Infect Dis. 2020;26:1324–1326. doi: 10.3201/eid2606.200299. - DOI - PMC - PubMed
    1. Lew S., Manes P., Smith B. Coinfection with SARS-CoV-2 and influenza a virus in a 32-year-old man. Am J Case Rep. 2020;21 doi: 10.12659/AJCR.926092. - DOI - PMC - PubMed

Publication types